Canada markets closed

Gan & Lee Pharmaceuticals. (603087.SS)

Shanghai - Shanghai Delayed Price. Currency in CNY
Add to watchlist
48.00-0.78 (-1.60%)
At close: 03:00PM CST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2022-12-31
2021-12-31
2020-12-31
Total Revenue
2,345,858
1,712,270
3,612,044
3,361,882
Cost of Revenue
381,953
405,804
396,111
306,653
Gross Profit
1,963,906
1,306,467
3,215,933
3,055,229
Operating Expenses
Research Development
517,037
562,469
474,589
419,985
Selling General and Administrative
1,141,897
1,171,065
1,100,620
1,014,820
Total Operating Expenses
1,844,505
1,870,741
1,756,370
1,625,471
Operating Income or Loss
119,401
-564,275
1,459,564
1,429,758
Interest Expense
-
776.0086
964.7303
-
Income Before Tax
242,147
-582,473
1,696,013
1,445,470
Income Tax Expense
74,609
-142,957
243,258
214,760
Income from Continuing Operations
167,538
-439,516
1,452,755
1,230,711
Net Income
167,538
-439,516
1,452,755
1,230,711
Net Income available to common shareholders
167,538
-439,516
1,452,755
1,230,711
Basic EPS
0.43
-0.78
2.59
2.31
Diluted EPS
0.43
-0.78
2.59
2.31
Basic Average Shares
569,312
563,483
560,909
532,775
Diluted Average Shares
569,312
563,483
560,909
532,775